A Phase 3 randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability and immunogenicity of a 21-valent PCV, V116, in pneumococcal vaccine-naive adults (STRIDE-3)
A Phase 3 randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability and immunogenicity of a 21-valent PCV, V116, in pneumococcal vaccine-naive adults (STRIDE-3)
저자
Bruno, Christopher; Buntinx, Erik; Pelayo, Enrique; Kamerbeek, Jackie M.; Garcia-Huidobro, Diego; Barranco-Santana, Elizabeth A.; Sjoberg, Folke; Song, Joon Young; Greenberg, David; Grijalva, Carlos G.; Orenstein, Walter A.; Morgan, Leslie; Fernsler, Doreen; Xu, Weifeng; Waleed, Muhammad; Li, Jianing; Buchwald, Ulrike K.; Platt, Heather L.